Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 19)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
9-Feb-10 New Constructs, LLC N/A ULGX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ULGX: the economy's impact on ULGX's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: UROLOGIX -- ULGX 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: BFRM , NCST , SPAN , ULGX , UTMD -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
2-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Urologix, Inc. 42 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: UROLOGIX INC 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: UROLOGIX INC 5 $25 View Abstract
22-Jan-10 Feltl & Company Ernest W. Andberg ULGX- Q2 ’10 revenues and bottom line better than expected, but still no guidance 7 $25 View Abstract
22-Jan-10 Feltl & Company Ernest W. Andberg ULGX- Q2 ’10 revenues and bottom line better than expected, but still no guidance 7 $25 View Abstract
21-Jan-10 Thomson StreetEvents N/A ULGX - Event Transcript of Urologix, Inc. conference call, Jan. 21, 2010 / 5:00pm ET 10 $75 View Abstract
Next 9

Brokerage Reports (Showing 1 to 3 of 3)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
22-Jan-10 Feltl & Company Ernest W. Andberg ULGX- Q2 ’10 revenues and bottom line better than expected, but still no guidance 7 $25 View Abstract
22-Jan-10 Feltl & Company Ernest W. Andberg ULGX- Q2 ’10 revenues and bottom line better than expected, but still no guidance 7 $25 View Abstract
21-Jan-10 Thomson StreetEvents N/A ULGX - Event Transcript of Urologix, Inc. conference call, Jan. 21, 2010 / 5:00pm ET 10 $75 View Abstract

Independent Reports (Showing 1 to 10 of 16)

Release
Date Contributor Author Title Pages Price More Info
9-Feb-10 New Constructs, LLC N/A ULGX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for ULGX: the economy's impact on ULGX's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: UROLOGIX -- ULGX 1 $4 View Abstract
5-Feb-10 Ford Investor Services, Inc. N/A Industry Value Graph: BFRM , NCST , SPAN , ULGX , UTMD -- MEDICAL SUPPLIES & EQUIPMENT 3 $4 View Abstract
2-Feb-10 Wright Reports N/A Wright Investors Service Comprehensive Report for Urologix, Inc. 42 $65 View Abstract
31-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: UROLOGIX INC 5 $25 View Abstract
24-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: UROLOGIX INC 5 $25 View Abstract
17-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: UROLOGIX INC 5 $25 View Abstract
13-Jan-10 Life Science Analytics Life Science Analytics Urologix Inc.-Company Report 13 $115 View Abstract
4-Jan-10 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: UROLOGIX INC 5 $25 View Abstract
Next 6

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.